Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
Us2.ai is revolutionizing the battle against heart disease by utilizing AI-driven ultrasound software that ensures heart health can be accessible to everyone. This innovative platform provides 45 automated echo parameters, such as strain analysis, and enables real-time interpretation of 2D and Doppler images. It seamlessly integrates with any ultrasound machine, producing zero-click, comprehensive reports that maintain high accuracy and can be easily compared with expert evaluations. The AI echo copilot from Us2.ai autonomously analyzes all heart chambers through both 2D and Doppler perspectives, incorporating global reference guidelines into detailed, real-time reports. Recently, the software obtained FDA clearance for Us2.v2, which also boasts 45 automated echo parameters, including strain analysis, representing a remarkable advancement in healthcare technology. Ultimately, Us2.ai aims to democratize echocardiography, ensuring that ultrasound technology is available to individuals regardless of their location or circumstances, thereby promoting better heart health for all. This commitment to accessibility and innovation positions Us2.ai at the forefront of the medical technology landscape.
Description
Qure.ai's qLC-Suite is a cutting-edge AI-driven tool aimed at improving the early identification and management of lung nodules, which is crucial for prompt lung cancer intervention. This solution delivers accurate measurements, thorough characterization, and 3D imaging of lung nodules, ensuring that opportunities for early treatment are not overlooked. It is capable of supporting both incidental and targeted screenings by efficiently identifying nodules and calculating their volume with just one click. Moreover, the system monitors volumetric changes over time, providing valuable insights into nodule development. The qLC-Suite is designed to integrate smoothly into current workflows, offering quick analysis and reporting that assist healthcare professionals in their decision-making processes. In addition to its analytical capabilities, it serves as a comprehensive platform for managing lung nodules, facilitating care coordination through intelligent prompts, providing hardware-agnostic image viewing for AI-enhanced chest X-rays and CT scans, enabling seamless sharing of scans across departments, and allowing for tailored notifications for cases of concern. Overall, qLC-Suite represents a significant advancement in lung cancer care, promoting timely interventions that can ultimately save lives.
API Access
Has API
API Access
Has API
Pricing Details
No price information available.
Free Trial
Free Version
Pricing Details
No price information available.
Free Trial
Free Version
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Deployment
Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Customer Support
Business Hours
Live Rep (24/7)
Online Support
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Types of Training
Training Docs
Webinars
Live Training (Online)
In Person
Vendor Details
Company Name
Us2.ai
Founded
2017
Country
Singapore
Website
us2.ai/
Vendor Details
Company Name
Qure.ai
Founded
2016
Country
United States
Website
www.qure.ai/product/lung-nodule-management
Product Features
Medical Imaging
Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management
Product Features
Medical Imaging
Automated Routing
Comparison View
Compliance Management
Data Import / Export
Diagnostic Reporting
Image Analytics
Treatment Planning
Workflow Management